Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT.
Swoboda R, Labopin M, Giebel S, Angelucci E, Arat M, Aljurf M, Sica S, Pavlu J, Socié G, Bernasconi P, Rigacci L, Tischer J, Risitano A, Rovira M, Saccardi R, Pioltelli P, Van Gorkom G, Vitek A, Savani BN, Spyridonidis A, Peric Z, Nagler A, Mohty M. Swoboda R, et al. Among authors: spyridonidis a. Bone Marrow Transplant. 2022 Mar;57(3):399-406. doi: 10.1038/s41409-021-01550-0. Epub 2022 Jan 15. Bone Marrow Transplant. 2022. PMID: 35031709
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Grüllich C, Bertz H, Spyridonidis A, Müller CI, Finke J. Grüllich C, et al. Among authors: spyridonidis a. Bone Marrow Transplant. 2008 May;41(10):845-50. doi: 10.1038/sj.bmt.1705989. Epub 2008 Jan 21. Bone Marrow Transplant. 2008. PMID: 18209719 Clinical Trial.
Outcomes of Hodgkin's lymphoma patients with relapse or progression following autologous hematopoietic cell transplantation.
Kaloyannidis P, Voutiadou G, Baltadakis I, Tsirigotis P, Spyridonidis A, Repousis P, Balta A, Tsimberis S, Karakasis D, Sakellari I, Dervenoulas I, Harhalakis N, Anagnostopoulos A. Kaloyannidis P, et al. Among authors: spyridonidis a. Biol Blood Marrow Transplant. 2012 Mar;18(3):451-7. doi: 10.1016/j.bbmt.2011.07.020. Epub 2011 Jul 29. Biol Blood Marrow Transplant. 2012. PMID: 21803018 Free article.
141 results